AACR logo

More articles from Other Topics: Oral Presentations - Proffered Abstracts

Abstract PR02: Antigen delivery targeting tumor-infiltrating macrophages leads to eradication of tumor highly resistant to immune checkpoint inhibitors
Daisuke Muraoka, Naozumi Harada, Naohiro Seo, Tae Hayashi, Keisuke Fujii, Rui Yamaguchi, Seiya Imoto, Satoru Miyano, Hideo Yagita, Kazunari Akiyoshi, Hiroshi Shiku

Cancer Immunology Research Mar 2017, 5 (3 Supplement) PR02; DOI: 10.1158/2326-6074.TUMIMM16-PR02
Abstract PR15: Engineering phagocytic signaling
Adam Williamson, Ron Vale

Cancer Immunology Research Nov 2016, 4 (11 Supplement) PR15; DOI: 10.1158/2326-6066.IMM2016-PR15
Abstract PR09: Identifying the epigenetic code of tumor-specific CD8 T cell dysfunction and therapeutic reprogramming
Mary Philip, Lauren Fairchild, Liping Sun, Agnes Viale, Steven Camara, Ellen Horste, Taha Merghoub, Jedd D. Wolchok, Christina S. Leslie, Andrea Schietinger

Cancer Immunology Research Nov 2016, 4 (11 Supplement) PR09; DOI: 10.1158/2326-6066.IMM2016-PR09
Abstract PR06: Genomic characterization of immune escape pathways in gastric cancer
Kai Wang, Suet Yi Leung

Cancer Immunology Research Oct 2015, 3 (10 Supplement) PR06; DOI: 10.1158/2326-6074.TUMIMM14-PR06

Main menu